111 Inc
NASDAQ:YI
EV/EBIT
Enterprise Value to EBIT
Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.
Market Cap | EV/EBIT | ||||
---|---|---|---|---|---|
CN |
111 Inc
NASDAQ:YI
|
112.6m USD | -1.4 | ||
ZA |
C
|
Clicks Group Ltd
JSE:CLS
|
76B Zac | 0 | |
ZA |
D
|
Dis-Chem Pharmacies Ltd
JSE:DCP
|
29.1B Zac | 0 | |
US |
Walgreens Boots Alliance Inc
NASDAQ:WBA
|
15.8B USD | 12 | ||
BR |
Raia Drogasil SA
BOVESPA:RADL3
|
47.4B BRL | 24.2 | ||
CN |
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
45.3B CNY | 23.2 | ||
JP |
MatsukiyoCocokara & Co
TSE:3088
|
949.2B JPY | 11 | ||
SA |
Al Nahdi Medical Company SCJSC
SAU:4164
|
17.6B SAR | 18.3 | ||
MX |
Corporativo Fragua SAB de CV
BMV:FRAGUAB
|
79.2B MXN | 8.9 | ||
JP |
Cosmos Pharmaceutical Corp
TSE:3349
|
558.6B JPY | 17.3 | ||
CN |
D
|
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
|
25.9B CNY | 19.1 |
EV/EBIT Forward Multiples
Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.